The European Union-India Free Trade Agreement (FTA), finalized in January 2026, marks a significant milestone in international trade policy. The agreement opens up new economic prospects in one of the world's fastest-growing markets, with significant implications for companies active in laboratory technology.

For FHI members, this agreement represents both new commercial opportunities and key strategic and operational priorities. The deal creates a free trade zone for 2 billion people, and with the gradual elimination of more than 90 percent of tariffs, the Indian market will become significantly more accessible to European companies.

Given the current volatile geopolitical situation, it is important that the agreement is ratified and ultimately implemented as soon as possible.[1]

Gateway to the fastest growing major economy

India is rapidly developing as a global economic power. With a population of 1.45 billion and an annual growth rate of approximately 7 percent, the country is among the fastest-growing major economies in the world. The EU has designated India as a major trading partner, with bilateral goods trade nearly doubling over the past decade.

For FHI members in laboratory technology, ranging from manufacturers of measurement and analytical techniques to suppliers of advanced life sciences equipment, this means a vast and dynamic sales market will become more accessible. India is investing heavily in modern research facilities, pharmaceutical production sites, and biotechnological innovation. Demand for high-quality European equipment is traditionally high in these sectors.

Tariff cuts and reduced trade barriers

The core of the FTA lies in lowering import tariffs and creating a more predictable business environment. The EU emphasizes that India's current trade regime is still relatively restrictive due to technical barriers to trade (TBTs), complex certification requirements, and deviations from international standards.

The trade agreement significantly reduces these barriers, which is especially relevant for laboratory equipment, which is often certified, precise, and technically complex. A more stable regulatory framework means fewer delays in approval processes, lower administrative costs, and faster market introductions.

In addition, the treaty is expected to lead to greater harmonization of standards in quality control, product safety, and data integrity. Some regulations will be brought closer to European standards, which will offer direct benefits to manufacturers of advanced analytical instruments and measurement technology.

Stimulus for export of laboratory technology and high-tech expertise

The EU sees great opportunities in exporting technology, machinery and infrastructure expertise to India, which is working intensively on industrialisation and modernisation of its research and manufacturing sectors.

For FHI members, this means increased demand for high-quality laboratory equipment, test and measurement instruments, and digitalization solutions. India aims to strongly foster innovation ecosystems in biotech, pharmaceuticals, chemistry, and environmental technology, among others. The treaty's analysis explicitly states that technology-intensive collaboration is one of the largest growth areas, including synergies in R&D, semiconductors, digital transformation, and green tech.

This creates opportunities in:

  • analytical instrumentation for pharmaceutical quality control;
  • lab automation and robotics;
  • environmental monitoring and process analysis;
  • data-driven lab infrastructures and validation software.

Improved collaboration and supply chain diversification

The FTA also functions as a strategic lever for supply chain diversification. India explicitly positions itself as an alternative to China in global value chains, while the EU aims to reduce its geopolitical dependencies.

This makes India an attractive partner for sourcing components, assembling instruments, or collaborating in R&D clusters. For FHI members, this means that new joint ventures, distribution networks, and manufacturing ecosystems in India are better protected and supported by clearer investment rules and a more predictable business environment.

Moreover, thousands of European companies are already active in India, which provides a solid basis for further chain integration and local service networks.

Sustainability requirements: new opportunities and operational challenges

While the treaty opens many doors, the changing European regulations also raise concerns. India points out that recent EU measures such as the Carbon Border Adjustment Mechanism (CBAM) and the EU Deforestation Regulation (EUDR) put additional pressure on exports to Europe. These rules particularly affect energy-intensive and agricultural goods.

For laboratory technology companies this has two implications:

  1. Indirect impact through the supply chain

FHI members sourcing Indian materials, semi-finished products, or components must consider carbon pricing mechanisms and stricter sustainability requirements. This may result in additional audits, traceability technology, and certification processes.

  1. New market opportunities in sustainability technology

These same regulations also create strong demand for advanced measurement and analysis technology needed to monitor emissions, provenance, and product sustainability. This can lead to growth in applications such as environmental labs, process analysis labs, and monitoring services.

A Strategic Opportunity for FHI Laboratory Technology

The EU–India Free Trade Agreement is considered one of the EU's most strategic and comprehensive trade deals in recent years.
For members of FHI Laboratory Technology, the agreement brings:

Advantages:

  • access to a huge and fast-growing innovative market;
  • lower tariffs and fewer technical barriers to trade;
  • better protection of investments and intellectual property;
  • growing demand for high-quality laboratory and measurement technology;
  • opportunities for collaboration in R&D, digitalisation and environmental technology.

Points of interest:

  • compliance with European sustainability requirements;
  • dealing with remaining Indian regulations that are not yet fully harmonized;
  • possible competitive pressure due to wider market opening for Indian products.

Overall, the agreement offers a powerful platform for growth, innovation, and the international positioning of the Dutch laboratory technology sector. For FHI members investing in international expansion, sustainable supply chains, and high-quality technology, the EU–India FTA therefore represents a significant strategic opportunity.

More information

Visit the website of the European Commission for detailed information on the EU-India Free Trade Agreement.

On the website of Netherlands Enterprise Agency More information can be found about the EU-India Free Trade Agreement and what it means for entrepreneurs.

[1] VNO-NCW and MKB-Nederland welcome the trade agreement between India and the European Union

Events

PLOT members meeting at TOPA Institute
March 24, 12:00 March 24, 4:30 PM
Webinar: NIS2 drives away suppliers. How to prevent it
March 31, 10:30 March 31, 11:30
FHI, federatie van technologiebranches